<DOC>
	<DOCNO>NCT00004778</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate effect thyrotropin-releasing hormone ( TRH ) severity initial lung disease occurrence chronic lung disease give antenatally woman threaten premature delivery . II . Evaluate possible mechanism effect TRH severity incidence chronic lung disease . III . Investigate whether deficiency endogenous cortisol and/or thyroid hormone birth influence severity lung disease development chronic lung disease .</brief_summary>
	<brief_title>Phase III Randomized , Double-Blind , Placebo-Controlled Study Antenatal Thyrotropin-Releasing Hormone Pregnant Women With Threatened Premature Delivery</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double-blind study . Participants stratify participate institution . Participants randomly assign 1 2 treatment group . The first group treat intravenous thyrotropin-releasing hormone ( TRH ) intramuscular injection betamethasone dexamethasone . The second group receive placebo place TRH . Postnatal therapy surfactant , prophylactic steroid , indomethacin allow .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Thyrotropin-Releasing Hormone</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Threatened premature delivery 24 30 week gestation , i.e . : Premature labor Premature rupture membrane Elective premature delivery medically indicate Fetal lung maturity immature unknown Prior/Concurrent Therapy No 72 hour since initial corticosteroid Patient Characteristics The following complication exclude : Fetal distress Amnionitis Severe maternal bleeding uncontrolled transfusion volume replacement Fetal maternal heart disease Significant fetal blood loss Maternal blood pressure 140/90 mm Hg high without treatment Maternal hyperthyroidism Maternal hyperprolactinemic condition Significant fetal anomaly Multiple gestation demise 1 fetus Nonimmune hydrops No participation clinical research project</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2001</verification_date>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>neonatal disorder</keyword>
	<keyword>rare disease</keyword>
	<keyword>respiratory distress syndrome</keyword>
</DOC>